Who is Keith Bradnam?

I am an Associate Project Scientist in the laboratory of Ian Korf at the UC Davis Genome Center. I first started my career in bioinformatics back in 1993 as a Masters student at the University of Manchester.  See my ImpactStory page for a more detailed overview of my publications and other scientific output. I am passionate about Open Science, the Oxford comma, and adding milk first when making tea.

As well as the thoughts that I gather together on this blog (which are also shared to the @ACGT_blog twitter account),  I can also be found talking about various issues relating to science on my own twitter account (@kbradnam). Additionally, I tweet a lot of links to papers and other resources relating to the field of 'omics' assembly (genome, transcriptome, and metagenome) via the Assemblathon twitter account (@assemblathon). There is also the (relatively new) Take-Home Message website, in which I write stories to accompany Abby Yu's amazing cartoons that touch on recent events from the world of biology.

In December 2015, I will be leaving UC Davis and heading back 'across the pond' to London, UK. Feel free to get in contact if you know of suitable openings relating to science communication/outreach and/or genomics/bioinformatics.


Search this blog

Looking for an old post of mine? Use this search box to find something.


Subscribe to this blog

You can subscribe to this blog as an RSS feed.  You can also subscribe via email, and receive a daily update (just one email sent in the evening). Your email address will not be used for any other purpose or shared with any 3rd parties:


What do I write about?

I try to consistently tag each of my blog posts, and below is the resulting tag cloud. More frequently used tags appear in a larger font size. Click on a tag to see a list of all posts that have that tag.


Subscribe to the RSS feed


Financial Disclaimer

From time to time I write about companies in the biotechnology sector, particularly companies that develop sequencing technologies. I do not own, and have never owned, shares in any biotechnology company. Nor do I have any other vested interest in such companies that might lead to a conflict of interest.